KGA-2727

N/A

Report date: 2025/01/26 17:09:04
NME

Base Information

Drug NameKGA-2727
Drug Alias NameKGA-2727
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/glucose cotransporter 1 inhibitors
TargetsSodium/glucose cotransporter 1
Therapy Area/IndicationsDiabetes MellitusCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryWorldUnited KingdomJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKissei Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKissei Pharmaceutical Co Ltd
Inactive CompaniesGlaxosmithkline PlcSumitomo Pharmaceuticals Co LtdDainippon Pharmaceutical Co Ltd
Active IndicationsCardiomyopathies
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A